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Abstract 
Hepcidin is the master regulator of systemic iron homeostasis and its dysregulation is observed in several chronic liver
diseases. Unlike the extracellular iron-sensing mechanisms, the intracellular iron-sensing mechanisms in the hepatocytes
that lead to hepcidin induction and secretion are incompletely understood. Here, we aimed to understand the direct role of
intracellular iron-loading on hepcidin mRNA and peptide secretion using our previously characterised recombinant HepG2
cells that over-express the cell-surface iron-importer protein transferrin receptor-1. Gene expression of hepcidin (HAMP) 
was determined by real-time PCR. Intracellular iron levels and secreted hepcidin peptide levels were measured by ferrozine
assay and immunoassay, respectively. These measurements were compared in the recombinant and wild-type HepG2 cells
under basal conditions at 30 min, 2 h, 4 h and 24 h. Data showed that in the recombinant cells, intracellular iron content was
higher than wild-type cells at 30 min (3.1-fold, p<0.01), 2 h (4.6-fold, p<0.01), 4 h (4.6-fold, p<0.01) and 24 h (1.9-fold,
p<0.01). Hepcidin (HAMP) mRNA expression was higher than wild-type cells at 30 min (5.9-fold; p=0.05) and 24 h (6.1-
fold; p<0.03), but at 4 h, the expression was lower than that in wild-type cells (p<0.05). However, hepcidin secretion levels 
in the recombinant cells were similar to those in wild-type cells at all time-points, except at 4 h, when the level was lower
than wild-type cells (p<0.01). High intracellular iron in recombinant HepG2 cells did not proportionally increase hepcidin
peptide secretion. This suggests a limited role of elevated intracellular iron in hepcidin secretion. 
Keywords Hepcidin · Iron · HAMP · Transferrin receptor · Iron-sensing · HepG2 cells 
Introduction 
The hepatocyte-derived iron-hormone hepcidin is the main
regulator of systemic iron homeostasis, whereby increased
circulatory iron levels cause increased hepcidin secretion
[1, 2]. Secreted hepcidin binds to the cell-surface iron-
exporter protein ferroportin on various cell types and causes
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intracellular degradation of both hepcidin and ferroportin
[3]. This impedes cellular iron efux via ferroportin into
the circulation and thereby prevents systemic iron elevation
[4]. Lack of hepcidin or insufcient hepcidin production in
response to systemic iron-loading characterises the genetic
disorders of iron-overload hereditary hemochromatosis [5]. 
Moreover, hepcidin suppression together with inefective
erythropoiesis contributes to iron-loading anaemias like
β-thalassemia [6], whereas excessive hepcidin induction
is observed in iron-refractory iron defciency anaemia [4] 
and in chronic infammatory state such as in cancers [7]. 
Dysregulation of iron and hepcidin is also observed in other
chronic liver conditions such as alcoholic liver disease,
NAFLD-NASH, viral hepatitis and diabetes [8]. In chronic
liver disease whether iron and hepcidin dysregulation is the
cause, consequence or mediator of the pathology is not fully
known, although hepcidin response to iron alterations appear
to be functional [9]. Thus, fully understanding the efect of
iron-loading on hepcidin secretion is of clinical value. 
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The extracellular iron-sensing mechanisms that induce
hepcidin expression in the hepatocytes have been better
characterised. Essentially, alterations in liver and plasma
iron distinctly activate the BMP–SMAD pathway to induce
hepcidin. Elevated liver iron is sensed by the hepatic
endothelial cells that secrete paracrine signals and thereby
simulate hepcidin induction in the hepatocytes, while plasma
iron-sensing by the hepatocytes and subsequent hepcidin
induction has been proposed to involve cell-surface proteins
HFE and TFR2 [6, 10]. While most of such studies focussed
on the extracellular iron-sensing by the hepatocytes, com-
paratively fewer studies have focussed on understanding the
intracellular iron-sensing mechanisms that mediate hepcidin
induction and secretion [11–14]. 
Along this line, the direct efect of high intracellular iron-
loading on hepcidin mRNA expression and secretion need to
be further investigated. This is important because previous
studies suggested a role of stored intracellular iron in the
induction of HAMP (gene encoding hepcidin) [15–17], and
also proposed its role in the maturation of pro-hepcidin to
bioactive hepcidin secreted in the circulation [18]. 
Thus, in this short study, we aimed to assess the exclu-
sive effect of high intracellular iron on hepcidin under
the hypothesis that the level of hepcidin secretion will be
directly proportional to iron-loading. Accordingly, we exam-
ined HAMP mRNA and hepcidin peptide secretion in the
recombinant transferrin receptor-1 (rec-TfR1) HepG2 cells,
as previously created and characterised by our group [19]. 
These cells over-express the cell-surface iron-importer pro-
tein TfR1 that can allow high cellular loading. 
Distinct from our previous study, here, we examined
HAMP expression, hepcidin secretion, and intracellular iron 
levels in rec-TfR1 HepG2 cells under FCS-supplemented
basal conditions over time in the absence of exogenous iron
treatments, and in the absence of other cells types to exclude
potential paracrine efects on hepcidin expression. Data were
compared with some of our previously published data on
Wild-type HepG2 cells [20] at each time-point. 
Materials and methods 
Cell culture and treatments 
Wild-type (Wt) HepG2 cells (Health Protection Agency, UK)
were maintained as previously described [11, 19, 20]. The
maintenance medium used for both cell lines included foetal
calf serum (FCS). To avoid the variability in the iron available
to the cells due to diferences in FCS batches, the same batch
of FCS was used for all experiments. Rec-TfR1 HepG2 cells
were previously created by our group and maintained accord-
ingly (19). For treatments, Wt and rec-TfR1 HepG2 cells were
seeded at a density of 5 × 105 per well in 6-well plates in the
maintenance medium; with and without hygromycin B for Wt
and rec-TfR1 HepG2 cells, respectively) for 72 h (h). The anti-
biotic hygromycin B was required in the maintenance medium
as a selection for exclusive growth of recombinant cells and
not required for the growth and maintenance of Wt HepG2
cells. To ensure that before beginning experimental observa-
tions, the extracellular environment (medium) of both the cell
lines was the same, Wt and rec-TfR1 HepG2 cells were incu-
bated in hygromycin-free maintenance media. This removed
media-imposed variability and eliminated the possibility of
any hygromycin-posed interference in hepcidin peptide meas-
urements by immunoassay, as hepcidin peptides had to be
measured in the cell culture medium post the experimental
time-point. Following 24 h of incubation in respective media,
fresh hygromycin-free maintenance media were added to the
wells. Cells were harvested for examination of parameters at
30 min, 2 h, 4 h and 24 h. 
Determination of intracellular iron content 
Cellular iron content was determined by ferrozine assay [21].
This was normalised to protein content quantifed by Bradford
method and the iron levels were expressed as nmoles iron/mg
protein, as previously described [11]. 
Gene expression analysis 
Primers (Invitrogen, UK) for gene expression analyses were
ACAGCCAGACAGACGGCACGA (F) and TTCGCCTCT
GGAACATGGGCATC (R) for HAMP, and GCCAAAAGG
GTCATCATCTC (F) and GGTGCTAAGCAGTTGGTGGT
(R) for GAPDH [19]. RNA was extracted, converted to cDNA
using QuantiTect reverse transcription kit (Qiagen, UK) and
assessed through real-time PCR by using Quantifast SYBR 
green kit (Qiagen, UK), as previously described [20]. Data
were analysed by the relative quantifcation method, Delta-
Delta Ct (∆∆Ct) and expressed as 2−ΔΔCt [22]. 
Hepcidin peptide measurement 
The hepcidin peptide secreted in cell culture media was meas-
ured by a well-described immunoassay by Busbridge et al. [19, 
23]. 
Statistical analysis 
Data analysis was performed using Student’s t test. The level
of signifcance was set at p<0.05. Data were presented as
mean±SEM. 
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Results 
High intracellular iron in rec‑TfR1 HepG2 cells 
As expected, intracellular iron content in rec-TfR1 HepG2
cells was signifcantly higher than that in Wt-HepG2 cells
at all time-points; 30 min (3.1-fold, p<0.01), 2 h (4.6-
fold, p<0.01), 4 h (4.6-fold, p<0.01) and 24 h (1.9-fold,
p<0.01) (Fig. 1). 
HAMP mRNA expression in rec‑TfR1 HepG2 cells 
In the rec-TfR1 HepG2 cells, HAMP mRNA expression
showed an interesting pattern when compared to the Wt-
HepG2 cells. In these recombinant cells, HAMP expression
was signifcantly higher than that in Wt-HepG2 cells at
30 min (5.9-fold, p=0.05) (Fig. 2). Following this, at 2 h,
the expression did not signifcantly difer from Wt-HepG2
cells (Fig. 2), and at 4 h, it was lower than Wt-HepG2 cells
(p<0.03) (Fig. 2). At 24 h, HAMP expression restored its
response to that observed at the 30 min time-point and was
signifcantly higher than Wt-HepG2 cells (6.1-fold; p<0.05)
(Fig. 2). 
Hepcidin peptide secretion by rec‑TfR1 HepG2 cells 
The pattern of hepcidin peptide secretion by the rec-TfR2
HepG2 cells was partly similar to the pattern of HAMP
mRNA responses. These cells secreted hepcidin at similar
levels to the Wt cells at 30 min and 2 h (Fig. 3). This was fol-
lowed by comparatively lower levels of hepcidin secretion at
4 h (p<0.01) (Fig. 3). Subsequently, at 24 h, hepcidin levels
were restored (similar to Wt-HepG2 cells) and matched its
Fig. 2 Hepcidin mRNA expression in rec-TfR1 HepG2 cells. HAMP
mRNA expression was measured in the recombinant cells at vari-
ous time-points in basal conditions by real-time PCR (normalised to 
GAPDH). *p≤0.05, **p<0.03. Data are expressed as mean±SEM 
(n=3) 
previous response at 30 min (Fig. 3). Notably, secreted hep-
cidin peptide levels in the recombinant cells did not exceed
levels in Wt-HepG2 cells at any time-point. 
Discussion 
Under physiological conditions, increased hepatic hepcidin
secretion in response to elevation in systemic iron levels
is a well-established phenomenon [4]. Since hepcidin/iron
dysregulation is observed in several hereditary and non-
hereditary chronic liver conditions, and hepcidin is recog-
nised as a useful biomarker for liver fbrosis and cirrhosis
[8, 24], investigation on iron-induced hepcidin response is
of immense clinical value. 
Fig. 1 Cellular iron-loading in rec-TfR1 HepG2 cells. Intracellular 
iron levels in the recombinant cells were measured at various time-
points in basal conditions by using the ferrozine assay and normalised 
to cellular protein content at corresponding time-points. *p<0.01. 
Data are expressed as mean±SEM (n=3) 
Fig. 3 Hepcidin peptide secretion in rec-TfR1 HepG2 cells. Hep-
cidin peptides secreted into the culture medium were measured in 
the recombinant cells at various time-points in basal conditions, as 
mentioned in the methods section. *p<0.01. Data are expressed as 
mean±SEM (n=3) 
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Several studies have investigated on the role of iron on
HAMP expression. Reviews by Kroot et al. [25], Wang et al. 
[26], Ganz [4] and Rishi et al. [27] elaborate the contribu-
tion of many groups in examining the signifcance of intra-
cellular iron stores and its efect on HAMP induction via
the BMP–SMAD pathway, and on overall transcriptional
regulation of hepcidin. However, less is known about the
post-translational life of hepcidin (i.e. mechanisms/modif-
cations and regulation of secretion), except the role of furin
convertase in the post-translational processing of 60-mer
pro-hepcidin [28], autoregulation of HAMP by pro-hepcidin 
[29] and intracellular localisation of hepcidin in mycobac-
teria-containing phagosomes of infected interferon-gamma-
activated cells that demonstrates the antibacterial nature
of hepcidin [30]. Thus, there is scarcity of information on
the regulation of 25-mer hepcidin at post-translational and
secretion stages and the role of intracellular iron in these
processes. Some reasons for comparatively fewer studies on
this topic may include focus on other aspects of hepcidin in
the early years following its discovery such as tackling the
challenges in the detection and quantifcation of hepcidin in
plasma and urine, difculties in obtaining hepcidin antibod-
ies due to its small size and limited availability of antigen
[31], establishment of standardised protocols for hepcidin
assays, identifcation and analysis of hepcidin in species
apart from mammals/human [32], examination of hepcidin-
inducing signalling pathways [27], clinical characterisation
of diferences in hepcidin levels in the diferent types of
hereditary hemochromatosis [33], analysis of hepcidin levels
and hepcidin:ferritin ratios for disease diagnosis [8, 25, 34] 
and usage of synthetic hepcidin in therapeutics [35]. 
While the mediators of extracellular iron-sensing by the
hepatocytes have been well studied [6, 36, 37], intracellular
iron-sensing mechanisms in the hepatocytes that afect the
induction and secretion of hepcidin are not fully understood.
Whether excess intracellular iron per se plays a direct role in
hepcidin induction and secretion remains enigmatic. 
Therefore, in this short study, we examined the exclusive
efect of high intracellular iron on HAMP mRNA expres-
sion and hepcidin peptide secretion in recombinant HepG2
cells under basal conditions, in the absence of exogenous
iron-loading and paracrine efects exerted by other liver
cell types. To achieve elevation in cellular iron, we used
our previously characterised rec-TfR1 HepG2 cells, which
over-express cell-surface TfR1 [19]. 
We confirmed cellular iron-loading in the rec-TfR1
HepG2 cells to ensure that the observed efects on hepcidin
were specifcally due to elevated intracellular iron (Fig. 1). 
Previously, it was proposed that iron may participate in the
maturation of pro-hepcidin into secreted bioactive hepci-
din [18], indirectly implying a direct relationship between
intracellular iron and hepcidin secretion levels at the post-
translational level. Accordingly, here, we hypothesised that
hepcidin secretion will be directly proportional to cellular
iron-loading. However, unlike HAMP mRNA expression
(Fig. 2), hepcidin peptide secretion in the recombinant cells
did not exceed levels in Wt cells at any time-point (Fig. 3), 
despite their several-fold higher intracellular iron content
(Fig. 1) and higher HAMP mRNA expression at 30 min and
24 h (Fig. 2). Thus, hepcidin secretion was not directly pro-
portional to intracellular iron-loading (Figs.1, 3), despite the
absence of mutations in iron-related genes, in which case
the disproportionality would be expected. These data are in
line with our previous observation in these cells where holo-
transferrin treatments (extracellular iron) combined with
increased intracellular iron content did not allow hepcidin
secretion in these cells to surpass the levels in Wt cells [19]. 
Although hepcidin secretion and intracellular iron did
not show direct proportionality as expected, comparison of
this data in rec-TfR1 HepG2 with our previously obtained
data in CHO-TRVb1 cells [20] may partially support the
proposed role of iron in hepcidin secretion [18]. The CHO
TRVb1 cells are well characterised Chinese hamster ovary
transferrin receptor variant cells that lack endogenous TfR1
and express iron-response-element-depleted human TFRC
mRNA [38], and over-express human TFR1 on cell surface
[20]. Previously, the CHO-TRVb1 cells did not difer from
the Wt-HepG2 cells in cellular iron content but showed
lower hepcidin secretion than Wt-HepG2 cells at the same
time-points as in this study [20]. Here, the rec-TfR1 HepG2
cells showed substantially higher intracellular iron than Wt-
HepG2 cells (Fig. 1), and although hepcidin secretion did
not exceed levels in Wt cells (Fig. 3), the levels were higher
than that in CHO-TRVb1 cells [20]. Thus, the comparatively
higher level of hepcidin secretion from the rec-TfR1 HepG2
than CHO-TRVb1 cells, in the perspective of corresponding 
comparisons with Wt-HepG2 cells, may be partly attrib-
uted to the higher cellular iron-loading in the former cells,
assuming the genetic diferences between the cell lines did
not infuence hepcidin response to iron. A limited but posi-
tive role of intracellular iron in hepcidin secretion can be
envisaged. 
Data showed higher HAMP mRNA expression in the
rec-TfR1 HepG2 cells compared to Wt cells at 30 min and
24 h (Fig. 2). This could be attributed to the higher cellular
iron content in these cells (Fig. 1); the mechanism likely
mediated via the previously established endogenous BMP6-
related iron-sensing mechanism [12, 13]. The decrement in
HAMP mRNA expression at 4 h (Fig. 2), which refected in
reduced hepcidin peptide secretion at 4 h (Fig. 3) followed
by the simultaneous restoration of levels at 24 h (Figs. 2, 3) 
is interesting and suggests a specifc time-based pattern of
HAMP regulation in these recombinant cells. As observed
here, several other studies have shown time-dependent alter-
ations/regulation of hepcidin. For example, Lakhal-Littleton
et al. observed that in control mice cardiomyocytes, HAMP
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mRNA expression gradually elevated and peaked at 8 h, then
decreased at 16 h when the levels were similar to that at 4 h
and remained unaltered thereafter up to 24 h. Similarly, hep-
cidin peptide levels generally increased and peaked at 4 h,
then dropped and subtly increased again, restoring levels to
that at 4 h [39]. Serum hepcidin levels in healthy individuals
have also shown time-related alterations and demonstrated
diurnal rhythm. For instance, Ganz et al. reported that in
comparison to the morning (8 am), hepcidin was higher at
noon and evening [40]. Girelli et al. showed that hepcidin
gradually increased and peaked at 12 h and returned to base-
line levels at 24 h [41]. Troutt et al. reinforced that hepcidin
demonstrated a diurnal rhythm with lowest concentrations
in the morning, followed by gradual increase during the day,
and then a decline in late evening [42]. Schaap et al. further
studied this and suggested that ferritin was the determinant
of basal hepcidin levels, and diurnal rhythm rather than
dietary iron mediated hepcidin alterations [43]. 
While these examples of time-related hepcidin regulation
spanned hours, hepcidin response has been observed to cover
several days. For instance, in rats, there was a delay of about
4 days between stimulated erythropoiesis and the elevation
in intestinal iron absorption. It was concluded that this was
due to the lag in hepcidin response and thereby the delay in
its action on mature villus enterocytes [44]. Other examples
include malaria infection in mice, in which liver hepcidin
expression increased during early stages to ofer protection
against infection and then decreased during late stages [45]. 
In human volunteers, hepcidin levels elevated after 3 days
of fasting and refeeding reversed this efect. It was postu-
lated that during fasting, erythropoiesis was suppressed to
withhold tissue iron for important cellular processes such as
oxidative respiration (iron-dependent cytochrome system in
the mitochondria). This decrement in erythropoiesis could
be sensed by the liver resulting in elevated hepcidin synthe-
sis and secretion [42]. Also, during menstrual cycle, there
is an initial decrease in hepcidin during menstruation, fol-
lowed by elevation and stabilisation in the second half of the
cycle [46, 47]. These scenarios refect the factors on which
hepcidin synthesis and secretion depend (such as iron status,
infammation, fasting, diurnal rhythm) and these form the
physiological basis for time-dependent regulation of hep-
cidin. Thus, such time-dependent alteration/regulation of
hepcidin exists to allow hepcidin responses to be executed
at specifc times and alter the responses according to body
conditions and circadian rhythm. 
The reduction in HAMP mRNA expression in the rec-
TfR1 HepG2 cells (Fig. 2) could be partly executed by the
over-expression of TfR1 in these cells. This is possible
because a similar response of reduced hepcidin secretion
was observed in the CHO-TRVb1 cells that also over-express
human TfR1 [20]. Thus, the existence of a TfR1-related
mechanism of hepcidin regulation can be envisioned. The
proposed role of TfR1 is further strengthened by the fact
that under physiological conditions, iron defciency reduces
hepcidin levels [48], but here, the recombinant cells were not
iron defcient (Fig. 1) and still a reduced hepcidin response
was observed at 4 h (Figs. 2, 3). A contradictory relationship
between iron and hepcidin was observed in the rec-TfR1
HepG2 cells whereby at 4 h, when the intracellular iron con-
tent was at its highest (Fig. 1), HAMP mRNA and secretion
levels were at their lowest (Figs. 2, 3). This suggests that
the BMP-6-mediated intracellular iron-sensing mechanism
to elevate hepcidin expression may be overruled by other
regulatory mechanisms (partly by the putative regulatory
efect of TfR1) at this time-point. However, these putative
mechanisms were surpassed at a longer time-point of 24 h
when intracellular iron content was at its lowest (Fig. 1), 
but HAMP mRNA response was elevated (Fig. 2) and hep-
cidin secretion was restored (Fig. 3). Thus, an endogenous
time-based regulatory efect of TfR1 on hepcidin expres-
sion can be envisaged and needs to be investigated further.
Interestingly, these cells resemble the scenario created due
to the mutation in TFRC (gene encoding TfR1) in human,
as recently identifed, which leads to increased cell-surface
TfR1 [49]. Our data may partly support the recently pub-
lished data indicating the essential role of TfR1 in tuning
hepcidin expression based on the level of iron-loading in
hepatocytes and reiterates the inhibitory function of TfR1
on hepcidin expression [50]. 
One physiological reason for the disconnect between
hepcidin mRNA and protein levels could be to generate an
intracellular stored stock of the peptide so that it is ready to
be released in the circulation immediately upon stimulus
and/or allow a time-related release, as observed in several
clinical studies [40–43]. To our knowledge, such a mecha-
nism involving hepcidin storage/accumulation in intracel-
lular vesicles and its regulated release has not been dem-
onstrated so far but does not exclude this possibility either;
particularly when hepcidin has been described as an iron-
hormone [51]. While it remains to be demonstrated, this
putative mechanism may be similar to that in insulin, where
insulin is stored intracellularly in vesicles with zinc in the
form of dense clustered granules and released upon stimula-
tion by circulating nutrients. Insulin exocytosis is stimulated
by elevation in intracellular calcium levels [52]. Similarly,
it is possible that hepcidin secretion may be enhanced due
to elevation in intracellular iron. This hypothesis formed the 
basis for the work presented here. 
Another reason for the disconnect or gap between hep-
cidin mRNA and protein levels could be to accommodate
for any regulation at post-translational or secretion stage to
mediate fne tuning of hepcidin exocytosis. Again, this is a
postulation and remains to be proven. Note that systemic
hepcidin levels are not only determined by systemic and
hepatocellular iron but also by hypoxia [53], erythropoiesis
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[54], infammation (IL-6, TGF-β1) [55], diurnal/circadian
rhythm [42], growth hormone [42], tissue specifcity, glu-
coneogenic signals [56] and pathological status [8]. Thus,
it is possible that the disconnect between HAMP mRNA 
and peptide levels (particularly in the hepatocytes) exist to
accommodate the alterations in cellular and physiological
conditions, and thereby contribute to the fne tuning of hep-
cidin in response to the aforementioned factors. 
With regards to the possible efect of cell culture condi-
tions on hepcidin production, here, the culture conditions
deployed (including the maintenance medium) were the most
basic, commonly used and well established for the growth
and maintenance of HepG2 cells. Thus, it is unlikely that cell
culture condition may be a factor in altering metabolic path-
ways or epigenetic regulation related to hepcidin. Moreover, 
the culture conditions for both, the Wt (control) and recom-
binant HepG2 cells (test) were the same before beginning
experimental observations, which may have nullifed any
diferences between the control and test culture conditions.
However, paracrine/autocrine signalling, whereby these cells
may release signalling molecules and target itself or neigh-
bouring cells may afect hepcidin production. For example,
infammatory cytokine such as interleukin (IL)-6, that may
be released by these cells could increase HAMP transcription
(hepcidin is a type II acute phase protein) [57]. In contrast,
cytokines involved in the type I infammatory response such 
as tumour necrosis factor-α inhibit hepcidin expression [58],
while IL1α does not induce hepcidin [59]. These infamma-
tory cytokines were not measured in this study. Hence their
exact paracrine efect on hepcidin could not be determined.
Similarly, growth factors like hepatocyte growth factor and
epidermal growth factor can inhibit the iron- and BMP6-
mediated HAMP induction [59]. Sex hormone estrogen
reduces circulating hepcidin [60] but treatment of HepG2
cells with E2 has shown to increase HAMP mRNA expres-
sion [61], while testosterone has shown to decrease HAMP
transcription [62]. However, these are relevant under physi-
ological conditions and not under the in vitro experimental
conditions deployed here. 
Our objective was to examine whether hepcidin secre-
tion was directly proportional to the elevation in intracellular
iron. So far, we have not come across a study that examines
the exclusive efect of excess intracellular iron on hepcidin
secretion levels, which makes the concept of this study novel
and interesting. Indeed, hepcidin peptide levels under physi-
ological and pathological conditions, and in response to iron
dosage have been measured in numerous clinical studies, in
animal models and in in vitro studies [8, 37, 40, 41, 57, 63, 
64]. Also, several studies have contributed to our knowledge
on hepcidin regulation at transcriptional level [59]. However,
the aim of such elite studies wasn’t to understand hepci-
din secretion mechanisms and determine the role of iron in
secretion or in the maturation of pro-hepcidin to bioactive
hepcidin. Thus, studies need to be conducted on understand-
ing the mechanism and regulation of hepcidin secretion. 
Future work could test the hypothesis that TFR1 contrib-
utes to hepcidin regulation. Hepcidin mRNA, intracellular
hepcidin peptide and levels of secreted hepcidin could be
determined overtime under iron-loaded, basal and iron-
depleted conditions. This could be done in Wt HepG2 cells/ 
primary hepatocytes and compared with corresponding data
from cell lines overexpressing human TFR1 such as the rec-
TfR1 HepG2 cells. Comparison of intracellular hepcidin
levels between the two cell lines under basal, iron-loaded
and iron-depleted conditions and examining whether intra-
cellular hepcidin peptides inhibit HAMP transcription may
provide further insights into hepcidin mRNA regulation by
hepcidin peptide. 
Conclusion 
Data showed that high intracellular iron levels in recombi-
nant HepG2 cells elevated HAMP mRNA expression but
did not proportionally increase hepcidin peptide secretion.
This suggests a limited role of iron in hepcidin peptide secre-
tion. A putative role of TfR1 in hepcidin regulation can be
envisioned. 
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